Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:38201508

Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer.

Fernán Gómez-Valenzuela · Ignacio Wichmann · Felipe Suárez · Sumie Kato · Enrique Ossandón · Marcela Hermoso · Elmer A Fernández · Mauricio A Cuello

Cancers · 2023 doi:10.3390/cancers16010080

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:38201508
kind
science-record
content_hash
sha256:bc8724d0cf937bda21b4d6be845e268c08533e6272c87037ef3d2c140a18aa0f
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T19:20:07Z
updated_at
2026-11-01T22:11:00Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer.
doi
10.3390/cancers16010080
pmid
38201508
authors array · 8 items
[0]
Fernán Gómez-Valenzuela
[1]
Ignacio Wichmann
[2]
Felipe Suárez
[3]
Sumie Kato
[4]
Enrique Ossandón
[5]
Marcela Hermoso
[6]
Elmer A Fernández
[7]
Mauricio A Cuello
journal
Cancers
year
2023
abstract
Chronic inflammation influences the tumor immune microenvironment (TIME) in high-grade serous ovarian cancer (HGSOC). Specifically, cyclooxygenase-2 (COX-2) overexpression promotes cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) expression. Notably, elevated COX-2 levels in the TIME have been associated with reduced response to anti-CTLA-4 immunotherapy. However, the precise impact of COX-2, encoded by PTGS2, on the immune profile remains unknown. To address this, we performed an integrated bioinformatics analysis using data from the HGSOC cohorts (TCGA-OV, n = 368; Australian cohort AOCS, n = 80; GSE26193, n = 62; and GSE30161, n = 45). Employing Gene Set Variation Analysis (GSVA), MIXTURE and Ecotyper cell deconvolution algorithms, we concluded that COX-2 was linked to immune cell ecosystems associated with shorter survival, cell dysfunction and lower NK cell effector cytotoxicity capacity. Next, we validated these results by characterizing circulating NK cells from HGSOC patients through flow cytometry and cytotoxic assays while undergoing COX-2 and CTLA-4 blockade. The blockade of COX-2 improved the cytotoxic capacity of NK cells against HGSOC cell lines. Our findings underscore the relevance of COX-2 in shaping the TIME and suggest its potential as a prognostic indicator and therapeutic target. Increased COX-2 expression may hamper the effectivity of immunotherapies that require NK cell effector function. These results provide a foundation for experimental validation and clinical trials investigating combined therapies targeting COX-2 and CTLA-4 in HGSOC.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:38201508
locator
sections[4] "2.2. Genetic Assessment of COX-2, CTLA-4, and Ovarian Tumor Immune Microenvironment" paragraph 2
quote
To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff.
[1] object · 3 fields
asset
source:pmid:38201508
locator
sections[11] "2.9. Statistical Analyses" paragraph 2
quote
Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:38201508
locator
sections[24] "Data Availability Statement" paragraph 2
quote
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:38201508
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE26193
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE26193
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:38201508
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3390/cancers16010080
sha256
sha256:ac27a9a2c6118ae7a6c2920b06eb1005ffcf07f13e24b4b321dee0e97642b4de
bytes
57558
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3390/cancers16010080
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC10778357
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE26193
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE26193
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE26193
version
null
note
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
access_statement_kind
data_availability_statement
sample_accessions array · 107 items
[0]
GSM642933
[1]
GSM642934
[2]
GSM642935
[3]
GSM642936
[4]
GSM642937
[5]
GSM642938
[6]
GSM642939
[7]
GSM642940
[8]
GSM642941
[9]
GSM642942
[10]
GSM642943
[11]
GSM642944
[12]
GSM642945
[13]
GSM642946
[14]
GSM642947
[15]
GSM642948
[16]
GSM642949
[17]
GSM642950
[18]
GSM642951
[19]
GSM642952
[20]
GSM642953
[21]
GSM642954
[22]
GSM642955
[23]
GSM642956
[24]
GSM642957
[25]
GSM642958
[26]
GSM642959
[27]
GSM642960
[28]
GSM642961
[29]
GSM642962
[30]
GSM642963
[31]
GSM642964
[32]
GSM642965
[33]
GSM642966
[34]
GSM642967
[35]
GSM642968
[36]
GSM642969
[37]
GSM642970
[38]
GSM642971
[39]
GSM642972
[40]
GSM642973
[41]
GSM642974
[42]
GSM642975
[43]
GSM642976
[44]
GSM642977
[45]
GSM642978
[46]
GSM642979
[47]
GSM642980
[48]
GSM642981
[49]
GSM642982
[50]
GSM642983
[51]
GSM642984
[52]
GSM642985
[53]
GSM642986
[54]
GSM642987
[55]
GSM642988
[56]
GSM642989
[57]
GSM642990
[58]
GSM642991
[59]
GSM642992
[60]
GSM642993
[61]
GSM642994
[62]
GSM642995
[63]
GSM642996
[64]
GSM642997
[65]
GSM642998
[66]
GSM642999
[67]
GSM643000
[68]
GSM643001
[69]
GSM643002
[70]
GSM643003
[71]
GSM643004
[72]
GSM643005
[73]
GSM643006
[74]
GSM643007
[75]
GSM643008
[76]
GSM643009
[77]
GSM643010
[78]
GSM643011
[79]
GSM643012
[80]
GSM643013
[81]
GSM643014
[82]
GSM643015
[83]
GSM643016
[84]
GSM643017
[85]
GSM643018
[86]
GSM643019
[87]
GSM643020
[88]
GSM643021
[89]
GSM643022
[90]
GSM643023
[91]
GSM643024
[92]
GSM643025
[93]
GSM643026
[94]
GSM643027
[95]
GSM643028
[96]
GSM643029
[97]
GSM643030
[98]
GSM643031
[99]
GSM643032
[100]
GSM643033
[101]
GSM643034
[102]
GSM643035
[103]
GSM643036
[104]
GSM643037
[105]
GSM643038
[106]
GSM643039
sample_count
107
group_sizes
null
group_sizes_basis
null
platform
570
taxon
Homo sapiens
title
Control of oxidative stress by miRNA and impact on ovarian tumorigenesis
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE30161
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30161
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE30161
version
null
note
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
access_statement_kind
data_availability_statement
sample_accessions array · 58 items
[0]
GSM746861
[1]
GSM746862
[2]
GSM746863
[3]
GSM746864
[4]
GSM746865
[5]
GSM746866
[6]
GSM746867
[7]
GSM746868
[8]
GSM746869
[9]
GSM746870
[10]
GSM746871
[11]
GSM746872
[12]
GSM746873
[13]
GSM746874
[14]
GSM746875
[15]
GSM746876
[16]
GSM746877
[17]
GSM746878
[18]
GSM746879
[19]
GSM746880
[20]
GSM746881
[21]
GSM746882
[22]
GSM746883
[23]
GSM746884
[24]
GSM746885
[25]
GSM746886
[26]
GSM746887
[27]
GSM746888
[28]
GSM746889
[29]
GSM746890
[30]
GSM746891
[31]
GSM746892
[32]
GSM746893
[33]
GSM746894
[34]
GSM746895
[35]
GSM746896
[36]
GSM746897
[37]
GSM746898
[38]
GSM746899
[39]
GSM746900
[40]
GSM746901
[41]
GSM746902
[42]
GSM746903
[43]
GSM746904
[44]
GSM746905
[45]
GSM746906
[46]
GSM746907
[47]
GSM746908
[48]
GSM746909
[49]
GSM746910
[50]
GSM746911
[51]
GSM746912
[52]
GSM746913
[53]
GSM746914
[54]
GSM746915
[55]
GSM746916
[56]
GSM746917
[57]
GSM746918
sample_count
58
group_sizes
null
group_sizes_basis
null
platform
570
taxon
Homo sapiens
title
Genomic Multivariate Predictors of Response to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE26193 not downloaded
[1]
asset:data:geo:GSE26193 licence not read
[2]
asset:data:geo:GSE30161 not downloaded
[3]
asset:data:geo:GSE30161 licence not read
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
reordered
quote
To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5.
[1] object · 10 fields
id
method-2
family
group_comparison
specific
welch_t_test
label
Group comparison
dsl_operations array · 1 item
[0]
welch_t
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Welch
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
KM
[3] object · 10 fields
id
method-4
family
flow_cytometry_analysis
specific
mfi
label
Flow cytometry analysis
dsl_operations array · 3 items
[0]
gate_population
[1]
quantify_mfi
[2]
compensation_matrix
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
event_table
evidence object · 3 fields
score
0.8
band
high
quote
MFI
targets array · 0 items
gaps array · 1 item
[0]
method.reader_differs_from_extractor
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE26193
[1]
GSE30161
resolved_accessions array · 2 items
[0]
GSE26193
[1]
GSE30161
statements array · 1 item
[0]
Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).
basis
The paper names GSE26193, GSE30161 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:38201508
[1]
data:geo:GSE26193
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE26193
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T19:04:54Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
17198
completion_tokens
2371
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:38201508
type
paper
label
pmid:38201508
[1] object · 3 fields
id
source:pmid:38201508
type
manuscript
label
PMID 38201508 full text
[2] object · 3 fields
id
data:geo:GSE26193
type
dataset
label
GEO GSE26193
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:38201508
type
paper
label
pmid:38201508
[1] object · 3 fields
id
source:pmid:38201508
type
manuscript
label
PMID 38201508 full text
[2] object · 3 fields
id
data:geo:GSE26193
type
dataset
label
GEO GSE26193
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-38201508
type
extraction
used array · 1 item
[0]
source:pmid:38201508
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE26193
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE26193
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:38201508
parent_hash
sha256:caa3ee7a9f9ae75dd85e389747cc8f5b900d4edfcb2699dca7736aaeaaefea7b
fork_of
null
gaps array · 9 items
[0]
asset:data:geo:GSE26193 licence not read
[1]
asset:data:geo:GSE26193 not downloaded
[2]
asset:data:geo:GSE30161 licence not read
[3]
asset:data:geo:GSE30161 not downloaded
[4]
execution.not_run
[5]
method.reader_differs_from_extractor
[6]
review.human_critique
[7]
review.independent_reader
[8]
review.machine_critique
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
flow_cytometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
ulating NK cells from HGSOC patients through flow cytometry and cytotoxic assays while undergoing COX-2
order_basis
paper_text_order:1112
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
er’s recommendations. Isolated NK cells were cultured in 24-well treated clear plates (3526, Costar C
[1]
m, and 50 μL or 500 IU of IL-2 (1 mg/mL). We cultured human cancer cell lines HeyA8 kindly donated
order_basis
paper_text_order:2366
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5.
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:38201508", "kind": "science-record", "revision": 3, "content_hash": "sha256:bc8724d0cf937bda21b4d6be845e268c08533e6272c87037ef3d2c140a18aa0f", "created_at": "2026-11-01T19:20:07Z", "updated_at": "2026-11-01T22:11:00Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer.", "doi": "10.3390/cancers16010080", "pmid": "38201508", "authors": ["Fernán Gómez-Valenzuela", "Ignacio Wichmann", "Felipe Suárez", "Sumie Kato", "Enrique Ossandón", "Marcela Hermoso", "Elmer A Fernández", "Mauricio A Cuello"], "journal": "Cancers", "year": 2023, "abstract": "Chronic inflammation influences the tumor immune microenvironment (TIME) in high-grade serous ovarian cancer (HGSOC). Specifically, cyclooxygenase-2 (COX-2) overexpression promotes cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) expression. Notably, elevated COX-2 levels in the TIME have been associated with reduced response to anti-CTLA-4 immunotherapy. However, the precise impact of COX-2, encoded by PTGS2, on the immune profile remains unknown. To address this, we performed an integrated bioinformatics analysis using data from the HGSOC cohorts (TCGA-OV, n = 368; Australian cohort AOCS, n = 80; GSE26193, n = 62; and GSE30161, n = 45). Employing Gene Set Variation Analysis (GSVA), MIXTURE and Ecotyper cell deconvolution algorithms, we concluded that COX-2 was linked to immune cell ecosystems associated with shorter survival, cell dysfunction and lower NK cell effector cytotoxicity capacity. Next, we validated these results by characterizing circulating NK cells from HGSOC patients through flow cytometry and cytotoxic assays while undergoing COX-2 and CTLA-4 blockade. The blockade of COX-2 improved the cytotoxic capacity of NK cells against HGSOC cell lines. Our findings underscore the relevance of COX-2 in shaping the TIME and suggest its potential as a prognostic indicator and therapeutic target. Increased COX-2 expression may hamper the effectivity of immunotherapies that require NK cell effector function. These results provide a foundation for experimental validation and clinical trials investigating combined therapies targeting COX-2 and CTLA-4 in HGSOC.", "claims": [{"id": "claim-method", "statement": "To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38201508", "locator": "sections[4] \"2.2. Genetic Assessment of COX-2, CTLA-4, and Ovarian Tumor Immune Microenvironment\" paragraph 2", "quote": "To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff."}, {"asset": "source:pmid:38201508", "locator": "sections[11] \"2.9. Statistical Analyses\" paragraph 2", "quote": "Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38201508", "locator": "sections[24] \"Data Availability Statement\" paragraph 2", "quote": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:38201508"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE26193"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE26193"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:38201508", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/cancers16010080", "sha256": "sha256:ac27a9a2c6118ae7a6c2920b06eb1005ffcf07f13e24b4b321dee0e97642b4de", "bytes": 57558, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/cancers16010080", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10778357", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE26193", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE26193", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE26193", "version": null, "note": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM642933", "GSM642934", "GSM642935", "GSM642936", "GSM642937", "GSM642938", "GSM642939", "GSM642940", "GSM642941", "GSM642942", "GSM642943", "GSM642944", "GSM642945", "GSM642946", "GSM642947", "GSM642948", "GSM642949", "GSM642950", "GSM642951", "GSM642952", "GSM642953", "GSM642954", "GSM642955", "GSM642956", "GSM642957", "GSM642958", "GSM642959", "GSM642960", "GSM642961", "GSM642962", "GSM642963", "GSM642964", "GSM642965", "GSM642966", "GSM642967", "GSM642968", "GSM642969", "GSM642970", "GSM642971", "GSM642972", "GSM642973", "GSM642974", "GSM642975", "GSM642976", "GSM642977", "GSM642978", "GSM642979", "GSM642980", "GSM642981", "GSM642982", "GSM642983", "GSM642984", "GSM642985", "GSM642986", "GSM642987", "GSM642988", "GSM642989", "GSM642990", "GSM642991", "GSM642992", "GSM642993", "GSM642994", "GSM642995", "GSM642996", "GSM642997", "GSM642998", "GSM642999", "GSM643000", "GSM643001", "GSM643002", "GSM643003", "GSM643004", "GSM643005", "GSM643006", "GSM643007", "GSM643008", "GSM643009", "GSM643010", "GSM643011", "GSM643012", "GSM643013", "GSM643014", "GSM643015", "GSM643016", "GSM643017", "GSM643018", "GSM643019", "GSM643020", "GSM643021", "GSM643022", "GSM643023", "GSM643024", "GSM643025", "GSM643026", "GSM643027", "GSM643028", "GSM643029", "GSM643030", "GSM643031", "GSM643032", "GSM643033", "GSM643034", "GSM643035", "GSM643036", "GSM643037", "GSM643038", "GSM643039"], "sample_count": 107, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Control of oxidative stress by miRNA and impact on ovarian tumorigenesis", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE30161", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30161", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE30161", "version": null, "note": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM746861", "GSM746862", "GSM746863", "GSM746864", "GSM746865", "GSM746866", "GSM746867", "GSM746868", "GSM746869", "GSM746870", "GSM746871", "GSM746872", "GSM746873", "GSM746874", "GSM746875", "GSM746876", "GSM746877", "GSM746878", "GSM746879", "GSM746880", "GSM746881", "GSM746882", "GSM746883", "GSM746884", "GSM746885", "GSM746886", "GSM746887", "GSM746888", "GSM746889", "GSM746890", "GSM746891", "GSM746892", "GSM746893", "GSM746894", "GSM746895", "GSM746896", "GSM746897", "GSM746898", "GSM746899", "GSM746900", "GSM746901", "GSM746902", "GSM746903", "GSM746904", "GSM746905", "GSM746906", "GSM746907", "GSM746908", "GSM746909", "GSM746910", "GSM746911", "GSM746912", "GSM746913", "GSM746914", "GSM746915", "GSM746916", "GSM746917", "GSM746918"], "sample_count": 58, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Genomic Multivariate Predictors of Response to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE26193 not downloaded", "asset:data:geo:GSE26193 licence not read", "asset:data:geo:GSE30161 not downloaded", "asset:data:geo:GSE30161 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "reordered", "quote": "To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5."}}, {"id": "method-2", "family": "group_comparison", "specific": "welch_t_test", "label": "Group comparison", "dsl_operations": ["welch_t"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Welch"}}, {"id": "method-3", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "KM"}}, {"id": "method-4", "family": "flow_cytometry_analysis", "specific": "mfi", "label": "Flow cytometry analysis", "dsl_operations": ["gate_population", "quantify_mfi", "compensation_matrix"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["event_table"], "evidence": {"score": 0.8, "band": "high", "quote": "MFI"}}], "targets": [], "gaps": ["method.reader_differs_from_extractor"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE26193", "GSE30161"], "resolved_accessions": ["GSE26193", "GSE30161"], "statements": ["Transcript per Million (TPM) RNA-seq expression and clinical data can be accessed and downloaded from Genomic Data Commons through the TCGA-biolinks R package and ICGC Data Portal for the AOCS cohort. Lastly, normalized RNA array data were downloaded from https://www.refine.bio/website (accessed on 20 July 2023)."], "basis": "The paper names GSE26193, GSE30161 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:38201508", "data:geo:GSE26193"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE26193"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:04:54Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 17198, "completion_tokens": 2371, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:38201508", "type": "paper", "label": "pmid:38201508"}, {"id": "source:pmid:38201508", "type": "manuscript", "label": "PMID 38201508 full text"}, {"id": "data:geo:GSE26193", "type": "dataset", "label": "GEO GSE26193"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:38201508", "type": "paper", "label": "pmid:38201508"}, {"id": "source:pmid:38201508", "type": "manuscript", "label": "PMID 38201508 full text"}, {"id": "data:geo:GSE26193", "type": "dataset", "label": "GEO GSE26193"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-38201508", "type": "extraction", "used": ["source:pmid:38201508"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE26193", "type": "accession_resolution", "used": ["data:geo:GSE26193"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:38201508", "parent_hash": "sha256:caa3ee7a9f9ae75dd85e389747cc8f5b900d4edfcb2699dca7736aaeaaefea7b", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE26193 licence not read", "asset:data:geo:GSE26193 not downloaded", "asset:data:geo:GSE30161 licence not read", "asset:data:geo:GSE30161 not downloaded", "execution.not_run", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "flow_cytometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["ulating NK cells from HGSOC patients through flow cytometry and cytotoxic assays while undergoing COX-2"], "order_basis": "paper_text_order:1112", "id": "assay:1"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["er’s recommendations. Isolated NK cells were cultured in 24-well treated clear plates (3526, Costar C", "m, and 50 μL or 500 IU of IL-2 (1 mg/mL). We cultured human cancer cell lines HeyA8 kindly donated"], "order_basis": "paper_text_order:2366", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["To build up the survival curves (using progression-free survival [PFS] as the primary clinical outcome), we used the KM plotter Survival Analysis Tool [30], considering the ratio of the prostaglandin-endoperoxide synthase 2, PTGS2 (the COX-2 gene) and CTLA4, and defined survival according to the median-based PTGS2/CTLA4 cutoff. Univariate/multivariate Cox proportional hazard regression analyses were performed for all variables using the ‘coxph’ function from the survival R package version 3.5–5."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}